News, Resources, & Updates

All
  • All
  • Articles
  • Calendar
  • Compliance
  • Newsletter
  • Position Statements
  • Press Release
  • Regulatory
  • Uncategorized

Recall Preparedness

By Mark Land, AAHP president November 20, 2017 Risks associated with the therapeutic use of healthcare products are real. Manufacturers and the U.S. Food and...

Upcoming Webinar to Highlight Homeopathic Drug Stability

MILWAUKIE, Ore. (Nov. 14, 2017) – The American Association of Homeopathic Pharmacists (AAHP) will host a two-part webinar series on stability studies for homeopathic drug...

Annual Certification of Drug Product Listings

By Leonard Krause, FDA Connect November 1, 2017 It is that time of year again. Days are getting shorter and colder, and AAHP members who...

New Drug Listing Requirement and Timetable Effective this Month

By Eric Foxman, AAHP Secretary October 1, 2017 The FDA recently introduced new requirements for the annual drug product reporting period and a new Structured...
The long term

The Long-Term Vision for AAHP

By Eric Foxman, AAHP secretary October 1, 2017 During the course of the summer, AAHP president Mark Land lead the various association committees in an...
Market research roundup

Market Research Roundup

By Eric Foxman, AAHP secretary October 1, 2017 The last weeks have seen a number of market research studies published that provide background, analysis, and...

Belladonna: A Clinical Snapshot

By Todd Hoover, MD September 1, 2017 The original proving of belladonna was conducted by Dr. Samuel Hahnemann, who found it to become a commonly...

How is Homeopathic Belladonna Made?

By Mark Land, AAHP president September 1, 2017 Belladonna, more commonly known as deadly nightshade, Atropa belladonna, devil's cherries, devil's herb, divale, dwale, dwayberry, great morel,...

What’s New at FDA?

By Mark Land, AAHP president September 1, 2017 I took a course several years ago titled Regulatory Intelligence. The first thing the professor said was,...